Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Smreti Vasudevan"'
Publikováno v:
Advances in Human Biology, Vol 14, Iss 4, Pp 337-342 (2024)
Introduction: Undifferentiated round cell tumours (URCTs) are rare and less researched Ewing-like mesenchymal tumours that primarily affect bones and soft tissues. Therapeutic options for advanced URCT are limited. Pazopanib, a multi-tyrosine kinase
Externí odkaz:
https://doaj.org/article/8e72a9f4463e4413aaa7810f4fe12b44
Autor:
Smreti Vasudevan, Anurag Mehta
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 5, Iss 4, Pp 777-778 (2022)
Externí odkaz:
https://doaj.org/article/3e31721cc3494cb68248d0dbc5268d3a
Autor:
Anurag Mehta, Smreti Vasudevan
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100398- (2021)
Background: The predictive value of rare epidermal growth factor receptor gene (EGFR) mutations for non-small cell lung carcinoma (NSCLC) patients remain elusive. We evaluated the distribution, clinicopathological association, tyrosine kinase inhibit
Externí odkaz:
https://doaj.org/article/56a0105f008343629a69350596e34b85
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73853c94898e52313b5065cffeae6840
https://doi.org/10.7759/cureus.32417
https://doi.org/10.7759/cureus.32417
Publikováno v:
Journal of cancer research and therapeutics. 18(3)
Glucose transporter 1 (GLUT1) facilitates the uptake of glucose in malignant cells. We investigated GLUT1 transcript expression in colorectal cancer (CRC) tumors and explored its relationship to clinicopathological features, diabetes condition, and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71de5251ef4f03b0267b8a2d38cb1ffd
https://pubmed.ncbi.nlm.nih.gov/35900536
https://pubmed.ncbi.nlm.nih.gov/35900536
Autor:
Manoj Kumar Panigrahi, Smreti Vasudevan, Ullas Batra, Sanjeev Sharma, Anurag Mehta, Moushumi Suryavanshi, Mumtaz Saifi
Publikováno v:
Applied Cancer Research, Vol 40, Iss 1, Pp 1-12 (2020)
Background Next-generation sequencing (NGS) based assay for finding an actionable driver in non-small-cell lung cancer is a less used modality in clinical practice. With a long list of actionable targets, limited tissue, arduous single-gene assays, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8c5360a27951783b5a285642e3f492
http://link.springer.com/article/10.1186/s41241-020-00089-8
http://link.springer.com/article/10.1186/s41241-020-00089-8
Publikováno v:
Polish journal of pathology : official journal of the Polish Society of Pathologists. 72(2)
Tag-sequencing is a modified next-generation sequencing (NGS) approach wherein targeted regions are tagged with unique molecular identifiers enabling error-free detection of rare genomic alterations. We aimed to perform this high- fidelity sequencing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::768335041b3896f5b4146f228750b897
https://pubmed.ncbi.nlm.nih.gov/34706518
https://pubmed.ncbi.nlm.nih.gov/34706518
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137614 (2015)
Cancer stem cells (CSCs) pose a serious obstacle to cancer therapy as they can be responsible for poor prognosis and tumour relapse. In this study, we have investigated inhibitory activity of the ginger-derived compound 6-shogaol against breast cance
Externí odkaz:
https://doaj.org/article/783112ac42fd4376aef7be0dce1152c8
Autor:
Irfan Chowdhary, Smreti Vasudevan, Gayatri Viswakarma, Manoj Kumar Panigrahi, Poojan Agarwal, Divya Doval, Nayana N Sriramanakoppa, Dushyant Kumar, Mumtaz Saifi, Anurag Mehta, Moushumi Suryavanshi
Publikováno v:
South Asian Journal of Cancer
Background: Lung cancer is the leading cause of cancer-related mortality worldwide. Genome-directed therapy is less toxic, prolongs survival and provides a better quality of life. Predictive biomarker testing, therefore, has become a standard of care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::986b58e3a4ce45be4e987729eb714fa4
https://doi.org/10.4103/sajc.sajc_373_18
https://doi.org/10.4103/sajc.sajc_373_18
Publikováno v:
PeerJ
BackgroundCancer patients, especially those receiving cytotoxic therapy are assumed to have a higher probability of death from COVID-19. We have conducted this study to identify the Case Fatality Rate (CFR) in cancer patients with COVID-19 and have e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6355ffd5994772f9c932f08e83aa42a2
https://doi.org/10.1101/2020.09.14.20194092
https://doi.org/10.1101/2020.09.14.20194092
